GERN vs. ABBV
Compare and contrast key facts about Geron Corporation (GERN) and AbbVie Inc. (ABBV).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: GERN or ABBV.
Correlation
The correlation between GERN and ABBV is 0.44, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Performance
GERN vs. ABBV - Performance Comparison
Loading data...
Key characteristics
GERN:
-1.02
ABBV:
0.82
GERN:
-1.70
ABBV:
1.18
GERN:
0.78
ABBV:
1.18
GERN:
-0.68
ABBV:
1.10
GERN:
-1.73
ABBV:
2.67
GERN:
38.33%
ABBV:
8.52%
GERN:
65.47%
ABBV:
27.67%
GERN:
-98.65%
ABBV:
-45.09%
GERN:
-98.06%
ABBV:
-11.46%
Fundamentals
GERN:
$815.26M
ABBV:
$336.23B
GERN:
-$0.21
ABBV:
$2.34
GERN:
-2.38
ABBV:
0.41
GERN:
7.01
ABBV:
5.86
GERN:
3.11
ABBV:
236.44
GERN:
$116.29M
ABBV:
$57.37B
GERN:
$113.80M
ABBV:
$44.44B
GERN:
-$119.87M
ABBV:
$16.33B
Returns By Period
In the year-to-date period, GERN achieves a -63.84% return, which is significantly lower than ABBV's 8.97% return. Over the past 10 years, GERN has underperformed ABBV with an annualized return of -10.55%, while ABBV has yielded a comparatively higher 15.94% annualized return.
GERN
-63.84%
-7.25%
-68.93%
-66.32%
-0.62%
-10.55%
ABBV
8.97%
9.58%
11.01%
22.54%
21.38%
15.94%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
GERN vs. ABBV — Risk-Adjusted Performance Rank
GERN
ABBV
GERN vs. ABBV - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Geron Corporation (GERN) and AbbVie Inc. (ABBV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Loading data...
Dividends
GERN vs. ABBV - Dividend Comparison
GERN has not paid dividends to shareholders, while ABBV's dividend yield for the trailing twelve months is around 3.36%.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
GERN Geron Corporation | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
ABBV AbbVie Inc. | 3.36% | 3.49% | 3.82% | 3.49% | 3.84% | 4.41% | 4.83% | 3.89% | 2.65% | 3.64% | 3.41% | 2.54% |
Drawdowns
GERN vs. ABBV - Drawdown Comparison
The maximum GERN drawdown since its inception was -98.65%, which is greater than ABBV's maximum drawdown of -45.09%. Use the drawdown chart below to compare losses from any high point for GERN and ABBV. For additional features, visit the drawdowns tool.
Loading data...
Volatility
GERN vs. ABBV - Volatility Comparison
Geron Corporation (GERN) has a higher volatility of 19.55% compared to AbbVie Inc. (ABBV) at 9.61%. This indicates that GERN's price experiences larger fluctuations and is considered to be riskier than ABBV based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading data...
Financials
GERN vs. ABBV - Financials Comparison
This section allows you to compare key financial metrics between Geron Corporation and AbbVie Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
GERN vs. ABBV - Profitability Comparison
GERN - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Geron Corporation reported a gross profit of 38.40M and revenue of 39.60M. Therefore, the gross margin over that period was 97.0%.
ABBV - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, AbbVie Inc. reported a gross profit of 11.20B and revenue of 13.34B. Therefore, the gross margin over that period was 83.9%.
GERN - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Geron Corporation reported an operating income of -16.70M and revenue of 39.60M, resulting in an operating margin of -42.2%.
ABBV - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, AbbVie Inc. reported an operating income of 3.73B and revenue of 13.34B, resulting in an operating margin of 28.0%.
GERN - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Geron Corporation reported a net income of -19.84M and revenue of 39.60M, resulting in a net margin of -50.1%.
ABBV - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, AbbVie Inc. reported a net income of 1.29B and revenue of 13.34B, resulting in a net margin of 9.6%.